GenoFocus Inc - Asset Resilience Ratio

Latest as of June 2025: 16.26%

GenoFocus Inc (187420) has an Asset Resilience Ratio of 16.26% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore 187420 asset base for the complete picture of this company's asset base.

Liquid Assets

₩22.00 Billion
≈ $14.91 Million USD Cash + Short-term Investments

Total Assets

₩135.28 Billion
≈ $91.67 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how GenoFocus Inc's Asset Resilience Ratio has changed over time. See 187420 net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down GenoFocus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of GenoFocus Inc.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩22.00 Billion 16.26%
Total Liquid Assets ₩22.00 Billion 16.26%

Asset Resilience Insights

  • Good Liquidity Position: GenoFocus Inc maintains a healthy 16.26% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

GenoFocus Inc Industry Peers by Asset Resilience Ratio

Compare GenoFocus Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Akzo Nobel NV
AS:AKZA
Specialty Chemicals 2.16%
China Minmetals Rare Earth Co Ltd
SHE:000831
Specialty Chemicals 0.91%
Huaibei Mining Holdings Co Ltd
SHG:600985
Specialty Chemicals 2.33%
LB Group Co Ltd
SHE:002601
Specialty Chemicals 4.81%
Zhejiang Runtu Co Ltd
SHE:002440
Specialty Chemicals 3.05%
HYDROGRAPH CLEAN POWER
F:M98
Specialty Chemicals 0.00%
Lily Group Co Ltd
SHG:603823
Specialty Chemicals 0.37%
Longkou Union Chemical Co. Ltd. A
SHE:301209
Specialty Chemicals 10.57%

Annual Asset Resilience Ratio for GenoFocus Inc (2014–2024)

The table below shows the annual Asset Resilience Ratio data for GenoFocus Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 57.30% ₩83.81 Billion
≈ $56.79 Million
₩146.26 Billion
≈ $99.12 Million
+19.65pp
2023-12-31 37.65% ₩36.84 Billion
≈ $24.97 Million
₩97.86 Billion
≈ $66.32 Million
+6.62pp
2022-12-31 31.03% ₩41.55 Billion
≈ $28.16 Million
₩133.91 Billion
≈ $90.75 Million
+9.41pp
2021-12-31 21.61% ₩25.61 Billion
≈ $17.36 Million
₩118.52 Billion
≈ $80.32 Million
-9.79pp
2020-12-31 31.40% ₩35.56 Billion
≈ $24.10 Million
₩113.23 Billion
≈ $76.73 Million
+6.71pp
2019-12-31 24.69% ₩22.27 Billion
≈ $15.09 Million
₩90.20 Billion
≈ $61.13 Million
+11.54pp
2018-12-31 13.16% ₩9.25 Billion
≈ $6.27 Million
₩70.33 Billion
≈ $47.66 Million
-18.24pp
2017-12-31 31.39% ₩22.02 Billion
≈ $14.93 Million
₩70.15 Billion
≈ $47.54 Million
-55.05pp
2016-12-31 86.44% ₩54.65 Billion
≈ $37.04 Million
₩63.23 Billion
≈ $42.85 Million
+83.64pp
2015-12-31 2.80% ₩856.00 Million
≈ $580.10K
₩30.52 Billion
≈ $20.69 Million
+2.41pp
2014-12-31 0.39% ₩66.00 Million
≈ $44.73K
₩16.94 Billion
≈ $11.48 Million
--
pp = percentage points

About GenoFocus Inc

KQ:187420 Korea Specialty Chemicals
Market Cap
$44.92 Million
₩66.28 Billion KRW
Market Cap Rank
#22416 Global
#1471 in Korea
Share Price
₩2275.00
Change (1 day)
-4.01%
52-Week Range
₩2270.00 - ₩3595.00
All Time High
₩17350.00
About

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phy… Read more